`
`
`
`
`Paper No. ___
`Filed: March 2, 2020
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________________
`
`ALPHATEC HOLDINGS, INC. and ALPHATEC SPINE, INC.,
`Petitioners,
`
`v.
`
`NUVASIVE, INC.,
`Patent Owner.
`_____________________________
`
`Case No. IPR2019-00362
`Patent No. 8,361,156
`_____________________________
`
`PATENT OWNER’S SUPPLEMENTAL SUR-REPLY
`
`
`
`
`
`I.
`
`INTRODUCTION
`Reply argument based on newly submitted references of Michelson ’770
`
`(EX1053) and McAfee (EX1054) is improper and should be treated accordingly.
`
`Reply argument is improperly new where it deviates, or attempts to change,
`
`the “thrust” of the challenge set forth in the petition. In re NuVasive, Inc., 841 F.3d
`
`966, 972 (Fed. Cir. 2016) (citing In re Leithem, 661 F.3d 1316, 1319 (Fed. Cir.
`
`2011) (“we have relied on the APA’s requirements to find a ‘new ground’ where
`
`‘the thrust of the rejection’ has changed.”). Here, the challenges advanced in the
`
`petition relied on modifying Brantigan according the modular assembly in Figs. 18
`
`and 19 of Michelson. Argument or evidence in the Reply that deviates from the
`
`modularity described by Michelson, or invites the Board to so deviate, is improper.
`
`Furthermore, it is well established that attempting to fill in the gaps
`
`identified by Patent Owner in the prima facie case presented in the petition with
`
`new evidence and argument is improperly new. E.g., Consolidated Practice Guide
`
`at 73 (“Petitioner may not submit new evidence or argument in reply that it could
`
`have presented earlier, e.g. to make out a prima facie case of unpatentability.”).
`
`II.
`
`PETITIONER’S ATTEMPTED RETREAT FROM THE
`“MODULARITY” OF MICHELSON IS IMPROPER
`Petitioner repeatedly asserts, throughout the petition materials, that a POSA
`
`would have been motivated to modify Brantigan according to the modular
`
`embodiment of Michelson (EX1032). E.g., Pet. 14, 72, 74 (“…combined in
`
`- 1 -
`
`
`
`modular fashion…”), 69 (“inserting the ‘oversized’ implant modularly”), 69 (“for
`
`insertion in a modular fashion”), 70 (“make the implants modular”), 73
`
`(“Michelson ’973 discloses the same modularity concept Brantigan describes”), 75,
`
`FN 12 (at least two 18.95 mm implants).
`
`Petitioner’s proffered rationale for adopting the modularity of Michelson to
`
`the implants of Frey or Brantigan was “to increase patient safety and minimize
`
`invasiveness.” Pet. 69.
`
`As required by statute, the Board instituted the case set forth in the petition.
`
`Paper 18, 33 (“permit[] a single implant to be inserted by a single procedure into
`
`the spine”), 33, 34-35 (“more than one spinal fusion implant 1000 may be
`
`combined in a modular fashion”) 35 (“half the width dimensions for various
`
`vertebrae implants based on Brantigan’s teaching to make the implants modular ”).
`
`The Reply advances several arguments indicating retreat from its previous
`
`reliance on the modularity of Michelson as illustrated in Figs. 18 and 19 in
`
`numerous respects. For example, the Reply (1) now asserts it never argued
`
`sequential insertion of modular members and combination within the disc space.
`
`Additionally, the Reply (16) claims Petitioner never suggested an implant up to
`
`37.9 mm wide, as would result from a modular implant of two 18.95 mm wide
`
`modules (18.95 + 18.95 = 37.9). While such arguments were advanced previously,
`
`NuVasive does not oppose Petitioner’s concession of such arguments going
`
`- 2 -
`
`
`
`forward. To the extent the Reply offers any argument in replacement, however, it
`
`should be rejected as untimely and improperly new.
`
`The Reply (2-5, 6, 13) cites to McAfee (EX1054) and Michelson ’770
`
`(EX1053). Neither reference describes a modular implant as in Michelson nor does
`
`Petitioner assert otherwise. Instead, the newly cited references present independent
`
`cylindrical cages, which the Reply (5, 12) describes as a “side-by-side”
`
`arrangement. Neither reference discusses Michelson, the modular embodiment of
`
`Michelson, or even recites the term “modular.” As such, McAfee (EX1054) and
`
`Michelson ’770 (EX1053) are irrelevant to the modularity theory described in the
`
`petition.
`
`The Board’s Order suggests that, to the extent possible, the supplemental
`
`briefing address new evidence/argument. The Reply, however, presents no cogent
`
`argument as to how these references relate to the petition arguments based on the
`
`modularity of Michelson. Whether the modular members are combined prior to
`
`insertion as stated in Michelson or inserted sequentially, Petitioner still fails
`
`explain how modifying a single implant to a multi-component assembly increases
`
`safety and minimizes invasiveness. To the extent Petitioner envisions some pivot
`
`away from the modular embodiment of Michelson and toward newly presented
`
`“side-by-side” cylindrical cages, none is explained. To the extent Petitioner invites
`
`the Board to fashion some new theory on its behalf, that of course is prohibited.
`
`- 3 -
`
`
`
`Under the guise of responsiveness, the Reply (4) suggests the newly
`
`submitted references clarify the state of the art generally, as well as respond to
`
`specific arguments regarding the state of the art. But the Reply (e.g., 1) does not
`
`address NuVasive’s arguments regarding state of the art either, which are
`
`incompletely and inaccurately stated in the Reply. See also Paper 37, 3.
`
`Petitioner’s expert overstated and exaggerated developments in the field in
`
`numerous instances, which called into question the reliability and credibility of the
`
`direct testimony. POR 13-19; EX2055, ¶¶36-66. One of several examples of such
`
`exaggerations was the assertion that “[b]y the 1990s, the use of non-bone interbody
`
`spinal fusion implants had become common place.” EX1002, ¶39. Petitioner’s own
`
`expert conceded during cross-examination that the first such implant he used was
`
`one not available until the 2003. EX2022, 20-21, 31-34; EX1002, ¶45.
`
`III. PETITIONER’S SUBMISSION OF MCAFEE IS A BELATED
`ATTEMPT TO FILL A VOID IN THE PRIMA FACIE CASE
`The petition relied exclusively on Baccelli as teaching the claimed
`
`arrangement of radiopaque markers. The petition states that “Baccelli instructs a
`
`POSA to include radiopaque markers in the middle of the sidewalls of the implant
`
`relative to the direction in which the implant is inserted” Pet. 31. The petition
`
`further states, based on Baccelli, that “POSA have found it obvious to position two
`
`markers in the middle (widest portion) of Brantigan’s sidewalls to allow surgeons
`
`- 4 -
`
`
`
`to align the markers with the spinous process during and after the implant is
`
`inserted laterally.” Id. (citing EX1002, ¶ 125).
`
`NuVasive established that Petitioner had misapprehended the content of
`
`Baccelli, including incorrectly labeling the dimensions of the Baccelli implant and
`
`that Baccelli does not teach any markers proximate the medial plane. POR 20-24
`
`(citing EX2055, ¶¶101-109). Moreover, while Petitioner relied on the spikes 24 of
`
`Baccelli, it ignored Baccelli’s express instruction that spikes 24 are to be disposed
`
`symmetrically about the sagittal midplane. POR 24. As such, importing the
`
`positioning of spikes 24 of Baccelli into other implants would not result in the
`
`marker configuration claimed in the challenged patent.
`
`NuVasive also challenged the rationale of the petition as conclusory, lacking
`
`evidentiary support, and parroting the same rationale that had previously been
`
`rejected by the Federal Circuit. POR 25-26.
`
`These deficiencies in the petition challenge as to the prima facie case cannot
`
`be cured in Reply. The petition relied on the deficient content of Baccelli, ignored
`
`disclosure in that reference that undermined its assertions, and attempted to recycle
`
`the same conclusory rationale that previously failed. Any attempt to cure such
`
`shortcomings by now turning to McAfee is improper.
`
`Under the guise of responsiveness, and in attempt to improperly shift the
`
`burden, the Reply (2-3) mischaracterizes NuVasive’s argument as somehow
`
`- 5 -
`
`
`
`attempting to prove that alignment of markers with the spinous process and the
`
`lateral ends of a vertebrae was a benefit realized after the priority date. See also
`
`Paper 37, 3. This is not what NuVasive argued. Instead, NuVasive correctly
`
`pointed out that Petitioner’s conclusory assertion was merely repeating a rationale
`
`that had already been rejected by the Federal Circuit as impermissible hindsight.
`
`POR 25-26 (citing In re NuVasive, Inc., 842 F.3d 1376, 1384 (Fed. Cir. 2016).
`
`In Reply (6), Petitioner argues that McAfee shows that POSAs knew the
`
`benefits of “aligning markers with the spinous process and lateral ends of the
`
`vertebrae.” Even if McAfee did show such an alignment — and it does not— this
`
`reference does not address whether a POSA would have found it obvious to
`
`position markers in the middle of Brantigan’s sidewalls, as well as in the leading
`
`and trailing ends of the implant, to allow surgeons to align the markers with the
`
`spinous process and the lateral ends of the vertebrae as argued in the petition.
`
`Petitioner asserts (at 2-3) that its McAfee-based arguments are not based on
`
`“impermissible hindsight,” even if true (and it is not) this assertion is irrelevant to
`
`the Baccelli-based arguments of the petition.
`
`Even if considered on the merits, McAfee fails to cure the deficiencies of
`
`Baccelli or the arguments in the petition regarding radiopaque marker positioning.
`
`Based on attorney argument, Petitioner claims McAfee shows radiopaque implant
`
`markers based on alleged areas of differing intensity in the reproduced radiograph.
`
`- 6 -
`
`
`
`McAfee does not teach radiopaque markers at all, much less radiopaque markers in
`
`the claimed configuration. McAfee also does not disclose benefits of alignment
`
`with the spinous process or lateral ends of a vertebrae. There is no spinous process
`
`visible in the identified figures and Petitioner’s attorney argument does not
`
`demonstrate otherwise.
`
`IV. CONCLUSION
`Petitioner’s Reply arguments that rely on Michelson ’770 (EX1053) and
`
`McAfee (EX1054) should be disregarded or stricken from the record.
`
`
`
`
`
`Date: March 2, 2020
`
`
`
`Respectfully submitted,
`
`
`/ Michael T. Rosato /
`Michael T. Rosato, Lead Counsel
`Reg. No. 52,182
`
`
`
`
`
`
`
`
`
`- 7 -
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`This is to certify that I caused to be served a true and correct copies of the
`
`foregoing Patent Owner’s Supplemental Sur-Reply, on this 2nd day of March,
`
`2020, on the Petitioner at the correspondence address of the Petitioner as follows:
`
`Jovial Wong
`Nimalka R. Wickramasekera
`David P. Dalke
`WINSTON & STRAWN LLP
`Alphatec-IPRs@winston.com
`
`
`
`
`
`
`
`Date: March 2, 2020
`
`
`
`Respectfully submitted,
`
`
`/ Michael T. Rosato /
`Michael T. Rosato, Lead Counsel
`Reg. No. 52,182
`
`
`
`
`
`- 8 -
`
`